82Chapter 5REFERENCES1. Bartlett RH, Gazzaniga AB, Jefferies MR,Huxtable RF, Haiduc NJ, Fong SW:Extracorporeal membrane oxygenation(ECMO) cardiopulmonary support ininfancy. Trans Am Soc Artif InternOrgans 1976; 22: 80-93.2. Bartlett RH, Gazzaniga AB, Huxtable RF,Schippers HC, O'Connor MJ, JefferiesMR: Extracorporeal circulation (ECMO) inneonatal respiratory failure. J ThoracCardiovasc Surg 1977; 74(6): 826-833.3. Coughlin MT, Angus DC: Economicevaluation of new therapies in criticalillness. Crit Care Med 2003; 31(1Suppl): S7-S16.4. Atkinson JB, Ford EG, Humphries B,Kitagawa H, Lew C, Garg M, et al: Theimpact of extracorporeal membranesupport in the treatment of congenitaldiaphragmatic hernia. J Pediatr Surg1991; 26(7): 791-793.5. D'Agostino JA, Bernbaum JC, Gerdes M,Schwartz IP, Coburn CE, Hirschl RB, etal: Outcome for infants with congentialdiaphragmatic hernia requiringextracorporeal membrane oxygenation:the first year. J Pediatr Surg 1995;30(1): 10-15.6. Graves ED, Loe WA, Redmond CR,Falterman KW, Arensman RM:Extracorporeal membrane oxygenationas treatment of severe meconiumaspiration syndrome. South Med J 1989;82(6): 696-698.7. Heiss K, Manning P, Oldham KT, CoranAG, Polley TZ, Wesley JR, et al: Reversalof mortality for congenital diaphragmatichernia with ECMO. Ann Surg 1989;209(2): 225-230.8. Lessin MS, Thompson IM, Deprez MF,Cullen ML, Whittlesey GC, Klein MD:Congenital diaphragmatic hernia with orwithout extracorporeal membraneoxygenation: are we making progress? JAm Coll Surg 1995; 181(1): 65-71.9. Meurs KPv, Newman KD, Anderson KD,Short BL: Effect of extracorporealmembrane oxygenation on survival ofinfants with congenital diaphragmatichernia. J Pediatr 1990; 117(6): 954-960.10. Staak FHJMvd, Haan AFJd, Geven WB,Doesburg WH, Festen C: Improvingsurvival for patients with high-riskcongenital diaphragmatic hernia byusing extracorporeal membraneoxygenation. J Pediatr Surg 1995;30(10): 1463-1467.11. Weber TR, Connors RH, Pennington DG,Westfall S, Keenan W, Kotagal S, et al:Neonatal diaphragmatic hernia. Animproving outlook with extracorporealmembrane oxygenation. Arch Surg1987; 122(5): 615-618.12. Bartlett RH, Roloff DW, Cornell RG,Andrews AF, Dillon PW, ZwischenbergerJB: Extracorporeal circulation in neonatalrespiratory failure: a prospectiverandomized study. Pediatrics 1985;76(4): 479-487.13. O'Rourke PP, Crone RK, Vacanti JP, WareJH, Lillehei CW, Parad RB, et al:Extracorporeal membrane oxygenationand conventional medical therapy inneonates with persistent pulmonaryhypertension of the newborn: aprospective randomized study. Pediatrics1989; 84(6): 957-963.14. Bifano EM, Hakanson DO, Hingre RV,Gross SJ: Prospective, randomizedcontrolled trial of conventional treatmentor transport for ECMO in infants withpersistent pulmonary hypertension(PPHN). Pediatr Res 1992; 31: 196A.15. Gross SJ, Bifano EM, D'Eugenio DB,Hakanson DO, Hingre RV: Prospective,randomized controlled trial ofconventional treatment or transport forECMO in infants with severe persistentpulmonary hypertension (PPHN): twoyear follow up. Pediatr Res 1994; 36:17A.
Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation in the Netherlands 8316. UK Collaborative ECMO Trial Group: UKcollaborative randomised trial ofneonatal extracorporeal membraneoxygenation. Lancet 1996; 348(9020):75-82.17. Pearson GD, Short BL: An economicanalysis of extracorporeal membraneoxygenation. J Intensive Care Med 1987;2(2): 116-120.18. Schumacher RE, Roloff DW, Chapman R,Snedecor S, Bartlett RH: Extracorporealmembrane oxygenation in termnewborns. A prospective cost-benefitanalysis. ASAIO J 1993; 39(4): 873-879.19. Walsh-Sukys MC, Bauer RE, Cornell DJ,Friedman HG, Stork EK, Hack M: Severerespiratory failure in neonates: mortalityand morbidity rates andneurodevelopmental outcomes. J Pediatrwa1994; 125(1): 104-110.20. Metkus AP, Esserman L, Sola A, HarrisonMR, Adzick NS: Cost per anomaly: whatdoes a diaphragmatic hernia cost? JPediatr Surg 1995; 30(2): 226-230.21. Drummond MF, O'Brien B, Stoddart GL,Torrance GW: Methods for the economicevaluation of health care programmes.New York: Oxford University Press;1997.22. Finkler SA: The distinction between costand charges. Ann Intern Med 1982;96(1): 102-109.23. Rogowski J: Measuring the cost ofneonatal and perinatal care. Pediatrics1999; 103(1): 329-335.24. Schwartz RM, Wilirich KK, Gagnon DE:Extracorporeal membrane oxygenation:cost, organization, and policyconsiderations. In Wright LL (eds):Report of the workshop on diffusion ofECMO technology. NIH publication no.93-3399. Washington, D.C.: U.S.Department of Health and HumanServices; 1993.25. Litsenburg Rv, Mos Nd, Edgell D,Gruenwald C, Bohn DJ, Parshuram CS:Resource use and health outcomes ofpaediatric extracorporeal membraneoxygenation. Arch Dis Child FetalNeonatal Ed 2005; 90(2): F176-F177.26. Haase GM, Kennaugh JM, Clarke DR:Adaptation of an ECMO team in the eraof successful alternative therapies forneonatal pulmonary failure. J PediatrSurg 1995; 30(5): 674-678.27. Jacobs P, Finer NN, Robertson CM,Etches P, Hall EM, Saunders LD: A costeffectivenessanalysis of the applicationof nitric oxide versus oxygen gas fornear-term newborns with respiratoryfailure: results from a Canadianrandomized clinical trial. Crit Care Med2000; 28(3): 872-878.28. Howard S, Mugford M, Normand C,Elbourne D, Grant A, Field D, et al: Acost-effectiveness analysis of neonatalECMO using existing evidence. Int JTechnol Assess Health Care 1996;12(1): 80-92.29. Roberts TE: Economic evaluation andrandomised controlled trial ofextracorporeal membrane oxygenation:UK Collaborative Trial. Br Med J 1998;317(7163): 911-916.30. Petrou S, Edwards L: Cost effectivenessanalysis of neonatal extracorporealmembrane oxygenation based on fouryear results from the UK CollaborativeECMO Trial. Arch Dis Child FetalNeonatal Ed 2004; 89(3): F263-F268.31. Festen C, Sengers RCA, Geven WB,Staak FHJvd, Schöller M, Fons G, et al:Final report of the Dutch InvestigativeMedicine Program 'ExtracorporealMembrane Oxygenation (ECMO) inneonates (OG 90-001)' [in Dutch].Nijmegen/<strong>Rotterdam</strong>: AcademischZiekenhuis Nijmegen/AcademischZiekenhuis <strong>Rotterdam</strong>/<strong>Erasmus</strong><strong>Universiteit</strong> <strong>Rotterdam</strong>; 1995.32. Elliott SJ: Neonatal extracorporealmembrane oxygenation: how not toassess novel technologies. Lancet 1991;337(8739): 476-478.
- Page 3:
COST-EFFECTIVENESS OF NEONATAL SURG
- Page 6 and 7:
DOCTORAL COMMITTEEPromotors:Prof.dr
- Page 9 and 10:
PUBLICATIONSChapters 2 to 7 are bas
- Page 11:
6ChapterINFORMAL CARE FOR CHILDREN
- Page 14 and 15:
2Chapter 11.1 BACKGROUND AND MOTIVA
- Page 16 and 17:
4Chapter 1provides a good overview
- Page 18 and 19:
6Chapter 1disability, and death of
- Page 21:
Introduction 9particular equity pri
- Page 25 and 26:
Introduction 1320. Oostenbrink JB,
- Page 27 and 28:
Introduction 1554. Heyman MB, Harma
- Page 29 and 30:
THE COST-EFFECTIVENESS OFTREATMENT
- Page 31:
Cost-Effectiveness of Treatment for
- Page 35 and 36:
Cost-Effectiveness of Treatment for
- Page 37 and 38:
Cost-Effectiveness of Treatment for
- Page 39 and 40:
Cost-Effectiveness of Treatment for
- Page 41 and 42:
Cost-Effectiveness of Treatment for
- Page 43 and 44: Cost-Effectiveness of Treatment for
- Page 45: Cost-Effectiveness of Treatment for
- Page 48 and 49: 36Chapter 3ABSTRACTBackground/Purpo
- Page 50 and 51: 38Chapter 33.2 MATERIALS AND METHOD
- Page 52 and 53: 40Chapter 3child's date of birth) a
- Page 54 and 55: 42Chapter 3diaphragm was closed (Ta
- Page 56 and 57: 44Chapter 3Total costs of treatment
- Page 58 and 59: 46Chapter 3Regarding the treatment
- Page 60 and 61: 48Chapter 3REFERENCES1. Stolk EA, P
- Page 62 and 63: 50Chapter 332. Jaillard S, Pierrat
- Page 64 and 65: 52Chapter 4ABSTRACTAims:To examine
- Page 66 and 67: 54Chapter 4Outcome measuresThe pati
- Page 68 and 69: 56Chapter 4Clearly, the symptoms st
- Page 70 and 71: 58Chapter 4The respondents did not
- Page 72 and 73: 60Chapter 4Table 4.4TAIQOL Scores o
- Page 74 and 75: 62Chapter 44.4 DISCUSSIONIn this pa
- Page 76 and 77: 64Chapter 4ACKNOWLEDGMENTSWe are in
- Page 78 and 79: 66Chapter 418. Coons SJ, Rao S, Kei
- Page 80 and 81: 68Chapter 5ABSTRACTObjective:Extrac
- Page 82 and 83: 70Chapter 5treatment. 26,27 Finally
- Page 84 and 85: 72Chapter 5CostsOnly direct costs w
- Page 86 and 87: 74Chapter 5summarized in Table 5.2.
- Page 88 and 89: 76Chapter 5Table 5.3 Direct Medical
- Page 90 and 91: 78Chapter 5Figure 5.3 illustrates o
- Page 92 and 93: 80Chapter 5severely ill newborns—
- Page 96 and 97: 84Chapter 533. Meinert CL: Extracor
- Page 98 and 99: 86Chapter 568. Hui TT, Danielson PD
- Page 100 and 101: 88Chapter 6ABSTRACTObjective:To inv
- Page 102 and 103: 90Chapter 6a rule. The health-relat
- Page 104 and 105: 92Chapter 6Regression analysis of h
- Page 106 and 107: 94Chapter 6that caregiving for thei
- Page 108 and 109: 96Chapter 6Table 6.5 CareQol Compar
- Page 110 and 111: 98Chapter 6children with a disabili
- Page 112 and 113: 100Chapter 6This study was of impor
- Page 114 and 115: 102Chapter 618. Poley MJ, Stolk EA,
- Page 116 and 117: 104Chapter 654. Boman KK, Viksten J
- Page 118 and 119: 106Chapter 7ABSTRACTMortality rates
- Page 120 and 121: 108Chapter 77.2 THE RELEVANCE OF CO
- Page 122 and 123: 110Chapter 7In the early 2000s, our
- Page 124 and 125: 112Chapter 7Table 7.1 Economic Eval
- Page 126 and 127: 114Chapter 7More from a policy pers
- Page 128 and 129: 116Chapter 7also expect that life-s
- Page 130 and 131: 118Chapter 7entirely justified, for
- Page 132 and 133: 120Chapter 723. Sydorak RM, Nijagal
- Page 134 and 135: 122Chapter 765. Glaser AW, Davies K
- Page 137 and 138: GENERAL DISCUSSION:A GUIDED TOURPRO
- Page 139 and 140: General Discussion: A Guided Tour P
- Page 141 and 142: General Discussion: A Guided Tour P
- Page 143 and 144: General Discussion: A Guided Tour P
- Page 145 and 146:
General Discussion: A Guided Tour P
- Page 147 and 148:
General Discussion: A Guided Tour P
- Page 149 and 150:
General Discussion: A Guided Tour P
- Page 151:
General Discussion: A Guided Tour P
- Page 154 and 155:
142GlossaryCharge (or: tariff)A pri
- Page 156 and 157:
144Glossaryefficient one. We are th
- Page 159 and 160:
SUMMARY
- Page 161 and 162:
Summary 149mortality. Finally, it i
- Page 163 and 164:
Summary 151neonatal surgery. It is
- Page 165 and 166:
SAMENVATTING
- Page 167 and 168:
Samenvatting 155zoals directe niet-
- Page 169 and 170:
Samenvatting 157Hoofdstuk 6 gaat ve
- Page 171:
Samenvatting 159vereisen, waarvoor
- Page 174 and 175:
162AcknowledgmentsAlthough I am ind
- Page 176:
About the AuthorBorn in De Meern (N